Guidance for individuals associated with the (UL1)

advertisement
CTSI
Suggested Format for Biosketch and Other Support Pages
Program Year 8 – 7/01/2013 through 6/30/2014
Biosketch Section C – Suggested Format
5 UL1 TR000042-08 (P.I. Kieburtz, Karl D.)
7/01/2011 - 6/30/2016
5 KL2 TR000095-08 (P.I. Kieburtz, Karl D.)
5 TL1 TR000096-08 (P.I. Kieburtz, Karl D.)
NIH/National Center for Research Resources and National Center for Advancing Translational
Sciences
The University of Rochester’s Clinical and Translational Science Institute
The major goal of this project is to make the University of Rochester Clinical and Translational
Science Institute an academic home for clinical and translational sciences, providing a
centralized, integrated infrastructure.
Role: [role within key function, name of key function]
NOTES:
1. The percent effort and amount of funding (direct dollars) are not noted on Biosketches, only on
Other Support pages.
2. The section containing the information on the UL1 grant, including major goals, should be copied
verbatim.
3. The section describing the role of the individual must be customized based on his or her role on the
grant. Many individuals will have roles on more than one key function, so repeat this section as
necessary.
4. Key function directors should describe their role as Principal Investigator or Co-Principal Investigator,
as appropriate.
5. Key function names are provided in the table below.
Key Function
Approach and Governance
Pilot Translational and Clinical Studies Incubator Program
Biomedical Informatics
Regulatory Knowledge and Support and Clinical Research Ethics
Clinical Research Resources and Facilities
Community Engagement and Research
Research Education, Training and Career Development
Upstate New York Translational Research Network (UNYTE)
Evaluation
Comparative Effectiveness Research
Public Private Partnerships
T1 Translations
Administrative Supplement
The University of Rochester Clinical and Translational Science Institute
Ltd Comp: Rev Apps to Advance Evidence-Based Research Related to Protections
for Humans Subjects
106747605
Page 1 of 3
CTSI
Suggested Format for Biosketch and Other Support Pages
Program Year 8 – 7/01/2013 through 6/30/2014
Other Support Pages - Suggested Format
5 UL1 TR000042-08 (P.I. Kieburtz, Karl D.)
7/01/2011 - 6/30/2016
5 KL2 TR000095-08 (P.I. Kieburtz, Karl D.)
5 TL1 TR000096-08 (P.I. Kieburtz, Karl D.)
NIH/National Center for Research Resources and National Center for Advancing Translational
Sciences
$3,198,387
The University of Rochester’s Clinical and Translational Science Institute
The major goal of this project is to create the University of Rochester Clinical and Translational
Sciences Institute as the academic home for clinical and translational sciences, providing a
centralized, integrated infrastructure.
Role: [role within key function, name of key function] xx.x person-months (cal)
xx% FTE
$xxx,xxx
Notes:
1. The section containing the information on the UL1 grant, including major goals, should be copied
verbatim. The annual direct costs of the program will be updated each program year.
2. The section describing the role of the individual must be customized based on his or her role on the
grant. Many individuals will have roles on more than one key function, so repeat this section as
necessary.
3. Key function directors should describe their role as Principal Investigator or Co-Principal Investigator,
as appropriate.
4. Key function names are provided in the table below. The dollar figure is the annual direct costs
related to the particular key function, as provided below. These are Year 8 figures; they will be
updated each year.
Key Function
Approach and Governance
Pilot Translational and Clinical Studies Incubator Program
Biomedical Informatics
Regulatory Knowledge and Support and Clinical Research Ethics
Clinical Research Resources and Facilities
Community Engagement and Research
Research Education, Training and Career Development
Upstate New York Translational Research Network (UNYTE)
Evaluation
Public Private Partnerships
T1 Translations
Comparative Effectiveness Research
TL1 Training Program
Mentored Career Development Award KL2 Scholar Program
106747605
Annual
Direct
Costs ($)
357,344
290,337
256,745
334,702
394,980
257,353
417,120
100,652
52,331
11,948
11,999
11,948
216,160
389,014
Page 2 of 3
CTSI
Suggested Format for Biosketch and Other Support Pages
Program Year 8 – 7/01/2013 through 6/30/2014
Administrative Supplement
The University of Rochester Clinical and Translational Science Institute
Ltd Comp: Rev Apps to Advance Evidence-Based Research Related to
Protections for Humans Subjects
106747605
Annual Direct
Costs ($)
95,755
Page 3 of 3
Download